Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Under Delaware's "Revlon doctrine," if your company is for sale, the board's fiduciary duty shifts. They are no longer guardians of the company's mission but are legally required to act as "auctioneers" to get the highest possible price for shareholders.

Related Insights

Most founders don't realize that boilerplate charter language like 'to pursue any lawful act or activity' legally binds them to shareholder primacy under Delaware law. This creates a critical divergence between a company's stated mission and its actual legal purpose.

Experienced board members provide maximum value by defining the acquisition framework and target criteria upfront. Their involvement in a specific deal's diligence is often too late, leaving them with only a "go/no-go" decision, a tool to be used sparingly, primarily to enforce the agreed-upon framework.

A board's duty to maximize shareholder value is an expected value calculation. A $100B offer with a 75% chance of closing is valued at $75B, making an $80B offer with 100% certainty more attractive. Boards weigh financing and regulatory risks heavily against the headline price.

Despite Warner Bros. having a "no shop" provision with Netflix, their board has a fiduciary duty to consider a superior offer. This creates a loophole where a persistent bidder like Paramount can force the target to re-engage, keeping the auction alive even after a winner is chosen.

Most founders don't realize the standard "any lawful purpose" clause in their corporate charter creates a fiduciary duty to maximize shareholder value. This seemingly innocuous phrase can legally compel a founder to accept a buyout from an undesirable acquirer, even with founder control.

The adage 'biotech companies are bought, not sold' means an acquisition is typically not the result of a company actively seeking a buyer. As with Portola's sale to Alexion, it is often a fiduciary responsibility to consider an unsolicited offer, even if the internal plan is independent growth.

The standard "any lawful act or purpose" clause in your startup's charter is not a grant of freedom. Courts interpret it as a fiduciary duty to maximize shareholder value, potentially forcing you to sell to the highest bidder, even if it contradicts your mission.

A 'hostile' takeover bid is not defined by personal animosity but by a specific procedural move. After being rejected by a target company's board, the acquirer bypasses them and makes their offer directly to the shareholders. The 'hostile' element is the act of circumventing the board's decision-making authority.

The default legal structure of most companies creates a fiduciary duty to maximize shareholder value. This isn't a suggestion; it can legally force a board to sell to the highest bidder, as seen when health company Vectura was forced to sell to Philip Morris, leading to its destruction.

A board's fiduciary duty is to maximize shareholder value, which is an expected value calculation (Offer Price x Probability of Closing). An $80B all-cash offer with 100% certainty is superior to a $100B offer with only a 75% chance of regulatory approval, as its expected value is higher ($80B vs. $75B).